Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06545669Phase 4Completed

C-Raven, a Virtual Tobacco Cessation Intervention in the Community

Role: collaborator

NCT05357404Active Not Recruiting

Age and Sex-Specific PREValence of AcqUirEd VALVular Heart DiseasE

Role: collaborator

NCT04575155Not ApplicableCompleted

Development & Pilot of the Technology-Enabled Alliance for Medication Therapy Management

Role: collaborator

NCT01471366Not ApplicableCompleted

Method of Fish Oil Administration on Patient Compliance

Role: collaborator

All 4 trials loaded